Our experience suggested that centralized monitoring of image quality is helpful for reducing quality defects in multicenter trials.
No takes yet. Share an insight, caveat, or question.
Gierada et al. (2009) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: